Cashmere Karen A.
Transaction: 07/11/2025
BUY
Change
+48,100
Price
$0.59
Filing
07/16/2025
Type
BUY
ZyVersa Therapeutics, Inc.
ZVSA • Biotechnology
$0.10
▲ +0.00 (+4.04%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$833.88M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Weak liquidity · 0.03Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 13, 2026, 12:00 AM UTCLast profile update: Sep 4, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.10
Change4.04%
Shares Out8.10B
Market Cap$833.88M
Enterprise Value$1.73B
52W Range0.08 - 0.30
Beta0.86
P/E-0.46
P/B-0.06
P/FCF-0.32
EV/EBITDA-71.13
EV/FCF-0.66
Price$0.10
Change4.04%
Shares Out8.10B
Market Cap$833.88M
Enterprise Value$1.73B
52W Range0.08 - 0.30
Beta0.86
P/E-0.46
P/B-0.06
P/FCF-0.32
EV/EBITDA-71.13
EV/FCF-0.66
Earnings Yield-217.79%
FCF Yield-314.34%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio0.03
Quick Ratio0.03
Volume3.45K
Avg Volume11.49K
EPS Surprise-0.13
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Manageable debt level · 0Weak liquidity · 0.03Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
SAPIRSTEIN JAMES
Transaction: 07/11/2025
BUY
Change
+11,066
Price
$0.59
Filing
07/15/2025
Type
BUY
Park Min-Chul
Transaction: 07/11/2025
BUY
Change
+11,066
Price
$0.59
Filing
07/15/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Cashmere Karen A. | BUY | +48,100 | $0.59 | 07/11/2025 | 07/16/2025 |
| SAPIRSTEIN JAMES | BUY | +11,066 | $0.59 | 07/11/2025 | 07/15/2025 |
| Park Min-Chul | BUY | +11,066 | $0.59 | 07/11/2025 | 07/15/2025 |
| Guzman Pablo A. | BUY | +48,900 | $0.59 | 07/11/2025 | 07/15/2025 |
| Wolfe Peter | BUY | +60,100 | $0.59 | 07/11/2025 | 07/15/2025 |
| Finizio Robert G | BUY | +11,066 | $0.59 | 07/11/2025 | 07/15/2025 |
| Glover Stephen C. | BUY | +136,900 | $0.59 | 07/11/2025 | 07/15/2025 |
| Freitag Gregory Gene | BUY | +11,066 | $0.59 | 07/11/2025 | 07/15/2025 |
| Finizio Robert G | BUY | +132 | $152.46 | 05/24/2023 | 07/18/2024 |
| SAPIRSTEIN JAMES | BUY | +132 | $152.46 | 05/24/2023 | 07/18/2024 |
| Freitag Gregory Gene | BUY | +132 | $152.46 | 05/24/2023 | 07/18/2024 |
| Park Min-Chul | BUY | +132 | $152.46 | 05/24/2023 | 07/18/2024 |
| Glover Stephen C. | BUY | +1,627 | $152.46 | 05/24/2023 | 07/18/2024 |
| Wolfe Peter | BUY | +715 | $152.46 | 05/24/2023 | 07/18/2024 |
| Cashmere Karen A. | BUY | +572 | $152.46 | 05/24/2023 | 07/18/2024 |
| INCON Co., Ltd. | OTHER | 0 | Not reported | 05/10/2023 | 08/03/2023 |
| Guzman Pablo A. | SELL | 0 | Not reported | 01/26/2023 | 01/26/2023 |
| Guzman Pablo A. | BUY | +100,000 | Not reported | 01/26/2023 | 01/26/2023 |
| Guzman Pablo A. | SELL | -9,015 | $6.90 | 12/12/2022 | 01/26/2023 |
| Freitag Gregory Gene | OTHER | — | Not reported | 01/05/2023 | 01/17/2023 |